无喹诺酮暴露史的儿科患者中分离出高水平喹诺酮耐药溶血嗜血杆菌
从一名9岁患者的吸出痰中分离出高水平喹诺酮耐药溶血嗜血杆菌,该患者接受家庭机械通气医疗护理2年,且>3年未暴露于任何喹诺酮类药物。分离株2019-19生化特征与流感嗜血杆菌相同,但全基因组分析显示更接近溶血嗜血杆菌。系统发育和质谱分析表明该菌株与溶血嗜血杆菌在同一簇,喹诺酮耐药决定区比较显示其具有多种氨基酸替换,包括与喹诺酮耐药相关的替换。
要点
- 从9岁患者吸出痰中分离出高水平喹诺酮耐药溶血嗜血杆菌。
- 患者接受家庭机械通气医疗护理2年,>3年未暴露于喹诺酮类药物。
- 菌株2019-19生化特征与流感嗜血杆菌相同,但全基因组分析更接近溶血嗜血杆菌。
核心结论
- 本报告强调从成人和儿童中均已分离出高水平喹诺酮耐药嗜血杆菌属物种。
研究设计与样本
- 从一名9岁患者的吸出痰中分离细菌并进行鉴定。
主要发现
- 分离株2019-19的生化特征与流感嗜血杆菌相同。
- 全基因组分析发现分离株2019-19更接近溶血嗜血杆菌。
- 系统发育和质谱分析表明菌株2019-19与溶血嗜血杆菌在同一簇。
- 喹诺酮耐药决定区比较显示菌株2019-19具有多种氨基酸替换,包括与喹诺酮耐药相关的替换。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prevalence of antimicrobial resistance among Haemophilus spp. is a critical concern, but high-level quinolone-resistant strains had not been isolated from children. We isolated high-level quinolone-resistant H. haemolyticus from the suction sputum of a 9-year-old patient. The patient had received home medical care with mechanical ventilation for 2 years and had not been exposed to any quinolones for >3 years. The H. haemolyticus strain we isolated, 2019-19, shared biochemical features with H. influenzae. However, whole-genome analysis found this strain was closer to H. haemolyticus. Phylogenetic and mass spectrometry analyses indicated that strain 2019-19 was in the same cluster as H. haemolyticus. Comparison of quinolone resistance-determining regions showed strain 2019-19 possessed various amino acid substitutions, including those associated with quinolone resistance. This report highlights the existence of high-level quinolone-resistant Haemophilus species that have been isolated from both adults and children.
引用
- Tanaka E, Hirai Y, Wajima T, et al. High-Level Quinolone-Resistant Haemophilus haemolyticus in Pediatric Patient with No History of Quinolone Exposure. Emerg Infect Dis. 2022. PMID: 34932443. doi:10.3201/eid2801.210248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。